Dap-ug, Jellfe E.
HRN: 22-12-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
AMPICILLIN 1GM (VIAL)
11/26/2023
11/27/2023
IV
2 G
Now Then Q6
PROM; MSAF Thinly
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes